What 'Zombie Cell' Research Means for Healthy Aging and Long-Term Care Planning
About This Article
Scientists call them zombie cells. As you age, damaged cells called senescent cells stop dividing but do not die, and they build up in your tissues, releasing inflammatory molecules associated with Alzheimer's disease, osteoarthritis, and cardiovascular disease.
Jacob Thomas
Jacob Thomas writes on health, wellness, and retirement topics, including aging, caregiving, insurance, and long-term care.
You have probably heard aging researchers talk about healthspan instead of lifespan. It is a real shift. Rather than simply helping you live longer, scientists want to help you stay healthier, longer. Scientists often refer to this field of study as geroscience, the study of the biological mechanisms that influence aging and age-related disease.
"The goal of geroscience is really to extend healthspan, and not necessarily lifespan." — Dr. Sofiya Milman, M.D., M.S. — Professor of Medicine and Genetics, and Director of Human Longevity Studies at Albert Einstein College of Medicine's Institute for Aging Research.
One of the most closely watched areas within geroscience is cellular senescence, and it may eventually reshape how families think about caregiving, retirement, and long-term care.
What Cellular Senescence Actually Is
As your cells age or become damaged, some of them stop dividing but refuse to die off. Researchers nicknamed them zombie cells. In small numbers, they are not necessarily harmful. But your immune system becomes less efficient at clearing them as you get older, so they accumulate over time.
The concern is what these cells do after they accumulate. They release inflammatory proteins, growth factors, and other signaling molecules that scientists call the senescence-associated secretory phenotype (SASP). That inflammation does not stay contained. It spreads to nearby healthy cells.
Nathan Basisty, Ph.D., a biochemist and principal investigator at the National Institute on Aging, studies how these cells behave in the body. He says senescent cells "will accumulate in virtually all of our tissues as we age," and that they are increasingly associated with illnesses of aging, including Alzheimer's disease and type 2 diabetes. Researchers are also examining whether the chronic inflammation these cells produce contributes to frailty, muscle loss, and a higher risk of illness later in life. None of this proves senescent cells directly cause these conditions. That link is still being studied.
Why Scientists Are So Focused on This
Aging researchers study several biological pathways to understand why some cells stop working properly. One example involves TGF-β signaling, a pathway involved in tissue repair and cell behavior that researchers can temporarily influence in the lab. Scientists also study apoptosis, the body's natural process for removing damaged cells, since a cell that fails to die properly can instead become senescent. Understanding that balance is a core part of aging research today.
One example is RepSox, a laboratory compound researchers use to inhibit TGF-β signaling temporarily. It is used to investigate how reducing TGF-β activity affects cellular reprogramming, cell identity, and senescence-related pathways.
Researchers also study apoptosis, the body's natural process of removing damaged cells through programmed cell death. Because damaged cells can either undergo apoptosis or enter a senescent state, understanding this balance is an important part of aging research.
Experimental studies have used Emricasan to temporarily suppress apoptosis, allowing researchers to investigate the relationship between cell survival, cell death, and senescence. It could also lead to a better understanding of how reduced cell death influences cellular senescence.
It is worth being clear here: the tools researchers use in these experiments are laboratory instruments, not medicines. Nothing in this research has been approved as an anti-aging treatment, and you should be skeptical of any product marketed that way.
James Kirkland, M.D., Ph.D., director of the Center for Advanced Gerotherapeutics at Cedars-Sinai and a pioneer of the senolytics field, has spent his career focused on this exact question. "What would happen if we got rid of senescent cells?"he recalls asking himself as he began the work that led to the first senolytic drugs. His work, and that of researchers across the field, is aimed at extending healthspan, the years a person spends healthy and independent, not simply extending how long someone lives.
What This Could Mean for Caregiving and Retirement Planning
This research is still in the laboratory and early clinical trial stages. But its long-term goal is practical, not theoretical. If scientists eventually find reliable ways to detect or slow age-related cellular damage, families could get more advance notice before a health crisis hits. That would mean more time to plan for caregiving, rather than making rushed decisions during a hospitalization or diagnosis.
It could also influence retirement timing, lifetime savings goals, workforce participation, and financial planning if people remain healthier for more years.
None of that is guaranteed, and none of it is available today.
What You Can Do Right Now
Viviana Perez Montes, Ph.D., director of the National Institute on Aging's Division of Aging Biology, has spent her career studying the biology of aging. Her research reflects a consistent message from the field: scientists have made real progress understanding why we age, but that knowledge has not yet turned into approved interventions that prevent or delay age-related disease.
"But if we scrutinize how much of this information has translated into interventions to prevent or delay aging and age-related diseases, the truth is, we're not yet where we want to be." — Viviana Perez Montes, Ph.D.
That gap matters for you today. According to the U.S. Department of Health and Human Services, 56 percent of Americans turning 65 will need long-term care, most commonly needing help with activities of daily living such as bathing or dressing, or supervision due to a memory decline. That risk exists whether or not the science of cellular senescence ever produces a treatment.
Medicare generally pays only for limited short-term skilled care following a qualifying hospitalization and does not cover most ongoing custodial long-term care. Long-Term Care Insurance helps pay for qualified care at home, in assisted living, memory care, or nursing homes, helping protect retirement assets while giving families greater flexibility when care becomes necessary.
Learn More: LTC News Long-Term Care Insurance Learning Center
Caregiving and Impact of Loved Ones – Still a Reality
Medical breakthroughs may eventually delay some age-related diseases, but family caregivers will remain central to helping loved ones recover from illness, manage chronic conditions, and remain safely at home, especially if you don't have Long-Term Care Insurance to pay for services. More than 63 million Americans are already unpaid family caregivers, making caregiving planning just as important as scientific progress.
The World Health Organization's Decade of Healthy Aging initiative calls for planning around changing care needs and building supportive environments that help older adults stay independent longer. That advice holds up regardless of what happens in a research lab. Review your retirement plan periodically.
Consider whether your financial strategy includes a plan for future long-term care expenses. Talk with your family about care preferences before a crisis forces the conversation. Be cautious of any supplement, medication, or treatment claiming to eliminate "zombie cells," reverse aging, or dramatically extend lifespan.
No therapy has been approved by the U.S. Food and Drug Administration specifically to treat normal aging by targeting cellular senescence. What the future holds is unknown, but research expands every day. However, aging often leads to chronic illness, mobility problems, dementia, and frailty, resulting in a need for help with daily living activities. Experts tell LTC News that planning, ideally before retirement, will ease the stress on those you love and protect income and assets from the rising cost of long-term care services.
Looking Ahead
The science behind cellular senescence is genuinely promising, but it is not a reason to wait. Use the LTC News Cost of Long-Term Care Services Calculator to see what care costs look like in your area. If you have a loved one who needs help now, you can browse our Caregiver Directory to compare local care providers and costs.
Frequently Asked Questions
Are zombie cells responsible for Alzheimer's disease and other illnesses?
Not conclusively. Researchers have found strong associations between senescent cells and conditions such as Alzheimer's disease, osteoarthritis, cardiovascular disease, type 2 diabetes, and frailty. However, scientists are still studying whether these cells directly cause these diseases or simply contribute to their development.
Why does this research matter for retirement and long-term care planning?
If scientists eventually learn how to delay or reduce some age-related diseases, people may enjoy more years of healthy, independent living. Even so, aging will still bring risks such as accidents, chronic illness, dementia, and mobility limitations. That is why planning for future long-term care remains important regardless of scientific advances.
Should I trust supplements that claim to reverse aging or eliminate zombie cells?
Be cautious. Many supplements and products make claims about reversing aging or removing senescent cells, but these claims are often unsupported by high-quality clinical evidence. Talk with your physician before taking any supplement marketed as an anti-aging treatment.
What is cellular senescence?
Cellular senescence is a natural biological process in which cells permanently stop dividing after experiencing damage or stress. Scientists believe this process helps protect the body early in life, but the buildup of senescent cells over time may contribute to age-related inflammation and chronic disease.
Are there approved treatments that eliminate zombie cells?
No. As of today, no therapy has been approved by the U.S. Food and Drug Administration specifically to treat normal aging by targeting cellular senescence. Most research remains in laboratory studies and early clinical trials.
What is healthspan?
Healthspan refers to the years of life spent in good health and free from significant disability. Many aging researchers now focus on extending healthspan rather than simply increasing lifespan.
What is geroscience?
Geroscience is the study of the biological processes that influence aging and age-related diseases. Rather than focusing on a single disease, researchers examine the underlying mechanisms of aging in hopes of helping people remain healthier and more independent for longer.
What is SASP?
SASP stands for senescence-associated secretory phenotype. It refers to the inflammatory proteins, growth factors, and other signaling molecules released by senescent cells. Researchers believe these substances may influence nearby healthy cells and contribute to chronic inflammation associated with aging.
What are "zombie cells"?
"Zombie cells" is the nickname researchers use for senescent cells—damaged cells that stop dividing but do not die as they normally should. While they can play a useful role in wound healing and preventing damaged cells from becoming cancerous, they tend to accumulate with age and release inflammatory substances that may affect nearby healthy cells.
What are senolytics?
Senolytics are experimental compounds designed to selectively eliminate senescent cells. They are an active area of research, but they are not approved anti-aging treatments, and scientists continue studying their safety and effectiveness.